Ownership as of September 30, 2021. Ten largest shareholders.
Name
Series A shares
Series B shares
Share capital %
Voting rights %
ANNWALL & ROTHSCHILD INVESTMENTS AB
377 736
510 478
7.91
29.32
SIX SIS AG, W8IMY
0
1 186 087
10.57
8.11
FJÄRDE AP-FONDEN
0
1 120 000
9.98
7.66
SWEDBANK ROBUR NY TEKNIK BTI
0
579 172
5.16
3.96
AMF AKTIEFOND SMÅBOLAG
0
501 585
4.47
3.43
TREDJE AP-FONDEN
0
501 579
4.47
3.43
UNIONEN
0
322 196
2.87
2.20
CBNY-NORGES BANK
0
321 989
2.87
2.20
DANGOOR, DAVID
0
306 421
2.73
2.10
ÅLANDSBANKEN I ÄGARES STÄLLE
0
261 759
2.33
1.79
Sub-total
377736
5 611 266
53.36
64.20
Other shareholders
0
5 237 182
46.64
35.80
Total
377736
10848448
100.00
100.00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.